Daniel S Loo

Summary

Affiliation: Boston University
Country: USA

Publications

  1. ncbi request reprint Cutaneous fungal infections in the elderly
    Daniel S Loo
    Department of Dermatology, Boston University School of Medicine, MA 02118, USA
    Dermatol Clin 22:33-50. 2004
  2. ncbi request reprint Systemic antifungal agents: an update of established and new therapies
    Daniel S Loo
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA
    Adv Dermatol 22:101-24. 2006
  3. ncbi request reprint Onychomycosis in the elderly : drug treatment options
    Daniel S Loo
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Drugs Aging 24:293-302. 2007
  4. doi request reprint Th17 cells: a new therapeutic target in inflammatory dermatoses
    Adam Asarch
    Department of Dermatology, Tufts Medical Center, Boston, Massachusetts 02111, USA
    J Dermatolog Treat 19:318-26. 2008
  5. ncbi request reprint Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts
    Eva M Volf
    Tufts University School of Medicine, Boston, MA 02111, USA
    J Drugs Dermatol 10:900-1. 2011
  6. ncbi request reprint Management of cutaneous human papillomavirus infection: pharmacotherapies
    Marigdalia K Ramirez-Fort
    Department of Dermatology, Tufts Medical Center, Boston, Mass, USA
    Curr Probl Dermatol 45:175-85. 2014
  7. ncbi request reprint AN-2690, a novel antifungal for the topical treatment of onychomycosis
    Orr Barak
    Tufts New England Medical Center, Department of Dermatology, 750 Washington Street, Boston, MA 02111, USA
    Curr Opin Investig Drugs 8:662-8. 2007
  8. doi request reprint Th17 cells: a new paradigm for cutaneous inflammation
    Adam Asarch
    Department of Dermatology, Tufts Medical Center, Boston, Massachusetts 02111, USA
    J Dermatolog Treat 19:259-66. 2008

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Cutaneous fungal infections in the elderly
    Daniel S Loo
    Department of Dermatology, Boston University School of Medicine, MA 02118, USA
    Dermatol Clin 22:33-50. 2004
    ..Successful management requires adequate patient education, correction of underlying predisposing factors, and prophylactic measures against recurrence...
  2. ncbi request reprint Systemic antifungal agents: an update of established and new therapies
    Daniel S Loo
    Department of Dermatology, Boston University School of Medicine, 609 Albany Street, Boston, MA 02118, USA
    Adv Dermatol 22:101-24. 2006
    ..Their metabolism is independent of hepatic cytochrome P450 enzymes, minimizing drug interactions. They are available only as i.v. formulations...
  3. ncbi request reprint Onychomycosis in the elderly : drug treatment options
    Daniel S Loo
    Department of Dermatology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
    Drugs Aging 24:293-302. 2007
    ..However, nail lacquers may be a good option as monotherapy for patients with superficial white onychomycosis or in combination with systemic antifungal therapy for patients with predisposing factors for poor response or recurrence...
  4. doi request reprint Th17 cells: a new therapeutic target in inflammatory dermatoses
    Adam Asarch
    Department of Dermatology, Tufts Medical Center, Boston, Massachusetts 02111, USA
    J Dermatolog Treat 19:318-26. 2008
    ..Newly developed treatment modalities for neutralizing the Th17 branch of the immune system are proving to be valuable additions to the current therapeutic armamentarium...
  5. ncbi request reprint Assessor-blinded study of the metabolic syndrome and surrogate markers of increased cardiovascular risk in children with moderate-to-severe psoriasis compared with age-matched population of children with warts
    Eva M Volf
    Tufts University School of Medicine, Boston, MA 02111, USA
    J Drugs Dermatol 10:900-1. 2011
    ..3 Here, we report the interim results of an ongoing study of MetS and CVD risk factors in pediatric psoriasis patients...
  6. ncbi request reprint Management of cutaneous human papillomavirus infection: pharmacotherapies
    Marigdalia K Ramirez-Fort
    Department of Dermatology, Tufts Medical Center, Boston, Mass, USA
    Curr Probl Dermatol 45:175-85. 2014
    ..Overall, given the high HPV recurrence rates, adjunctive use of antiviral agents should be considered in treatment, especially when managing severe or complicated presentations...
  7. ncbi request reprint AN-2690, a novel antifungal for the topical treatment of onychomycosis
    Orr Barak
    Tufts New England Medical Center, Department of Dermatology, 750 Washington Street, Boston, MA 02111, USA
    Curr Opin Investig Drugs 8:662-8. 2007
    ..Phase II and IIb trials with AN-2690 are underway...
  8. doi request reprint Th17 cells: a new paradigm for cutaneous inflammation
    Adam Asarch
    Department of Dermatology, Tufts Medical Center, Boston, Massachusetts 02111, USA
    J Dermatolog Treat 19:259-66. 2008
    ..Here we describe a new schema for dermatologic T-cell-mediated immunity. We elucidate experiments confirming the presence of Th17 cells, followed by a discussion of their relevance to cutaneous inflammation and psoriasis...